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ORIGINAL ARTICLE 
High serum neopterin and low cytokine values may 
indicate a non-bacterial etiology for fever of unknown 
origin in neutropenic patients 
Clin Microbiol Infect 1998; 4: 491-496 
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Objective: To prospectively evaluate serum neopterin, a marker of cellular immune activation, in relation to blood 
culture findings and cytokine levels (tumor necrosis factor-a (TNF-a), interleukin (IL)-l receptor antagonist, interferon-y 
(IFN-y), IL-6, and IL-10) at start of fever in neutropenic patients with hematologic malignancies. 
Methods: Serum samples were obtained during the first 24 h after start of fever in  27 episodes of febrile neutropenia 
seen in 22 patients. 
Results: Neopterin levels increased significantly at start of fever (time 0) compared to  baseline values (samples 
obtained within 72 h before start of fever). Neopterin levels peaked at 2-4 h after start of fever and returned to  baseline 
levels after 12 h. At start of fever no differences in neopterin values were seen with regard to  blood culture findings (i.e. 
blood-culture-negative (BCN) fever episodes versus Gram-positive bacteria versus Gram-negative bacteremia). In five 
of seven BCN fever episodes, in patients without other clinical evidence of infection, a high neopterin/low TNF-a value 
was observed and the correlation (r-value) between neopterinFNF-a was negative in  BCN fever episodes (-0.9; p<0.04), 
as opposed to  the bacteremic episodes, where the correlation was positive (0.7; p<0.04). 
Conclusion: The results of this study show that febrile neutropenic patients are able to react with increased neopterin 
values, and that some BCN fever episodes are characterized by high neopterin/low cytokine values which may be due 
to  an occult non-bacterial infection. 
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INTRODUCTION 
With the introduction of modern chemotherapy and 
radiotherapy, an increasing fraction of patients with 
previously lethal malignant diseases can be cured. 
Myelosuppression is often the dose-limiting toxicity, 
and the resulting neutropenia constitutes a major threat 
to the patient. During profound neutropenia most 
patients develop fever, and in 20-40% a manifest 
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bacteremia is documented [l]. In most series, for 
approximately half of the patients with fever during 
neutropenia, a reason for the fever is lacking (i.e. fever 
of unknown origin) (FUO)) [2,3]. Neutropenic patients 
are capable of responding with high systemic levels 
of proinflammatory (tumor necrosis factor-a (TNF-a), 
interleukin-1 (IL-1), IL-6, IL-8) and anti-inflammatory 
(IL-1 receptor antagonist (IL-lra) and IL-10) cytolunes 
during serious infections [4-91. The highest cytokine 
values (i.e. TNF-a and IL-6) have been documented in 
patients with Gram-negative bacteremia [9-111. How- 
ever, cytokine values do not discriminate between 
FOU and fever episodes due to bacteremia with low- 
virulence Gram-positive bacteria, such as coagulase- 
negative staphylococci [9]. 
Neopterin is a marker of cellular immune activation, 
and serum and urine concentrations increase in parallel 
to the clinical course of many viral infections [12]. 
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Neopterin has also been used as an indicator of im- 
munologic complications in allograft recipients [ 131. 
Furthermore, neopterin levels correlate with the severity 
of multiple organ failure in patients with sepsis [14,15]. 
Gram-positive bacteria often produce exotoxins 
that may act as 'superantigens' and activate large numbers 
of T-cells 1161. Activated T-cells produce interferon-y 
(IFN-y) which tnay in turn stimulate monocytes/ 
macrophages to release neopterin 1171. Thus, high 
neopterin values could be anticipated in Gram positive 
bacteremia, and neopterin may have the capacity to 
differentiate between Gram-positive bacteremias and 
FUO in the neutropenic patient. 
In the present study, neopterin, TNF-a, IL-1 ra, 
IFN-y, IL-6 and IL-10 were monitored for 24 h after 
start of fever in neutropenic patients with hematologic 
malignancies. The aim was to identify a relationship 
between neopterin values, the clinical status of the 
patient, type of bacterial etiology and cytokine levels. 
MATERIALS AND METHODS 
Patients 
Serum samples were collected during 27 fever episodes 
in 22 patients with hematologic disorders including 
acute myelocytic leukemia (n=17), acute lymphocytic 
leukemia (n=3),  Hodgkins disease ( n = l )  and severe 
aplastic anemia ( n = l ) .  There were 15 women andseven 
men with a median age of 50 years (range 18-85 years). 
The study was approved by the ethics committee of 
the Karolinska Institute, and the patients were included 
after informed consent was obtained. 
Patients who developed fever (>38.0"C on two 
occasions with at least a 4-h interval or >38.5"C on 
one occasion) during neutropenia (granulocyte count 
<0.5 X lO'/L) were studied. Fever episodes clearly 
associated with the administration of known pyrogenic 
substances (i.e. blood transfusions, granulocyte and 
granuiocyte/macrophage colony-stimulating factors 
or IFN-a) were not included. Blood cultures were 
obtained at start of fever and antibiotic therapy started. 
Two patients had serum creatinine values above 
normal, 131 and 125 mmol/L respectively (normal 
<120 mmol/L). All other patients had normal serum 
creatinine values. 
Antimicrobial therapy 
All patients received prophylactic fluconazole and 
acyclovir therapy. No antibacterial prophylaxis was 
given. In three episodes the patients were treated with 
broad-spectrum antibiotics at  the start of a new fever, 
and therapy was modified after blood cultures were 
obtained. In 22 episodes the patients were randomized 
in a trial of empirical therapy to either ceftazidime 
( ~ ~ 1 1 )  or amikacdco-trimoxazole ( n = l l )  131. In the 
remaining two episodes patients were treated with 
imipenem/cilastatin and amikacin/vancomycin, respec- 
tively. 
Clinical outcome 
One patient died due to septic shock within 48 h. This 
patient had the highest recorded neopterin value in this 
study (156 nmol/L). All other patients survived the 
first 72 h after start of fever. In 12 episodes antibiotic 
therapy was modified during this time. There was no 
difference in neopterin levels between episodes with 
change of antibiotic therapy within 72 h and the 
remainder (data not shown). 
Serum samples 
Blood samples were obtained at time 0 (one to three 
samples together with blood culture collection), and. 
when possible, after 2, 4, 6, 12 and 24 h. After clotting 
the tubes were immediately centrifuged and serum was 
stored at -20°C overnight. The aliquots were then 
transported to the laboratory and stored at  -70°C until 
the day of analysis. 
Serum samples obtained within 72 h before start of 
fever were analyzed to obtain a baseline level. These 
samples were collected three times a week and stored 
in a refrigerator (<+8"C) for, at most, 2 h, centrifuged, 
and then stored at -70°C until the day of analysis. A 
median of three samples was obtained for each fever 
episode (range one to seven samples). 
Fever episodes 
Patients were divided into three categories depending 
on the outcome of blood cultures: Gram-negative, 
Gram-positive and blood-culture-negative (BCN) epi- 
sodes. To minimize the risk of including false-positive 
bacteremias, two out of three blood cultures with 
coagulase-negative staphylococci had to be positive. 
Seven Gram-negative, nine Gram-positive and 1 1 
BCN fever episodes were recorded. N o  episode with 
mixed etiology was documented. 
The patients were also categorized according to 
their blood pressure reaction during the study period: 
hypotension (HT) was defined as systolic blood pressure 
<90mmHg and a decrease of 230mmHg below 
baseline pressure for the patient (n=6).  Remaining 
episodes were categorized as non-hypotension (n=16, 
non-HT). 
Neopterin determination 
Neopterin was determined with a quantitative com- 
petitive enzyme immunoassay (Henning Berlin, Berlin 
GMBH). In short, serum samples were added to 
the wells of microtiter plates coated with goat-anti- 
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neopterin antibody. Thereafter, enzyme-labeled neop- 
terin was added to the wells and, after incubation 
and washing, the substrate, nitrophenyl phosphate, was 
added. The reaction was stopped by addition of sodium 
hydroxide. The color measured as optical density (OD) 
at 405 nm is inversely proportional to the neopterin 
concentration in the serum sample. Results were 
calculated from a standard curve. Measurements and 
calculations were done in a Dynatech ME1 7000. 
Reference values (95% confidence interval) for normal 
blood donors (n=18) were 4-12 nmol/L. The labora- 
tory quality control system accepts only test runs with 
a CV <15%. 
0 
: : ; , [ ,  A ‘1 
Cytokine determinations 
All cytokines were determined by sandwich enzyme- 
linked immunosorbent assays in accordance with the 
instructions of the manufacturers. TNF-a, IFN-y and 
IL-10 assays (EASIA) were developed by Medgenix 
Diagnostics SA (Fleurs, Belgium), and IL-lra and 
IL-6 assays (Quantikme) by Research and Diagnostic 
Systems Inc. (Minneapolis, MN, USA) [9]. Reference 
values for the cytokines were determined by analysis 
of sera from 30 healthy blood donors. Ninety-five 
per cent confidence intervals were as follows: TNF-a 
25-95 pg/mL, IL-lra 70-670 pg/mL, IFN-y 0.1-1 .O 
pg/mL, IL-6 1-24 pg/mL and IL-10 0.1-1.6 pg/mL. 
The laboratory quality control system accepts only test 
runs with a coefficient of variation <15%. 
Statistical analysis 
In patients with more than one recorded fever episode 
‘“1 * * 
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Time (hours before and after start of fever) 
Figure 1 Serum neopterin levels (mean &95% confidence 
interval) before and during the first 24 h after start of fever 
in 27 neutropenic fever episodes in patients with hemato- 
logic malignancies. *p<O.Ol compared with -72 to 0 h 
before start of fever. 
( n = 3 ) ,  the first episode per patient per category was 
utilized in the different comparisons (i.e. BCN versus 
Gram-positive versus Gram-negative and HT versus 
non-HT). For comparison between groups the Mann- 
Whitney U-test was used. Only values from the first 
fever episode per patient were utilized for calculation 
of correlations (r-value) between neopterin and cytokmes. 
Calculations of correlations were studied by Spearman 
rank correlation test (Statwiew SE + Graphics). 
Differences between proportions were studied by 
Fisher’s exact test. All values are given as median with 
range. Due to multiple testing, a p-value <0.04 was 
considered significant. 
Increased neopterin levels (>12.0 nmol/L) were seen 
in 25 of the 27 fever episodes studied (93%). The 
neopterin level increased significantly at  start of fever 
(median 49 nmol/L, range 6-156 nmol/L) compared 
with ‘base-line level’ (i.e. samples obtained up to 72 h 
prior to start of fever, 11 nmol/L, 4-116 nmol/L; 
y<0.01, Figure 1). Neopterin levels peaked at 2-4 h 
after start of fever, and values returned to baseline at  
12 h (Figure 1). 
There were no differences in neopterin levels with 
regard to blood culture findings at start of fever (Figure 
2). One patient with Gram-negative bacteremia (n=7) 
had a neopterin level below 40 nmol/L, compared to 
three out of nine and five out of 11 in the Gram- 
positive and BCN groups, respectively (1/7 versus 
8/20; not significant). 
Figure 2 Serum neopterin values in neutropenic patients 
at start of fever in relation to blood culture findings. Blood- 
culture-negative (BCN), (n=1 l), Gram-negative (Gr-) 
bacteremia (n=7) and Gram-positive (Gram+) bacteremia 
(n=9). Box plot diagram showing me&an values: boxes; 
25th and 75th percentile; vertical bars, 10th and 90th 
percentile; circles, minimum and maximum values. 
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There was no statistically significant difference in 
neopterin levels between patients with H T  (50 nmol/L, 
6-156 nmol/L) and the non-HT group (45 nmol/L, 
8-143 nniol/L) at start of fever or at peak value 
2-24 h after start of fever (HT 57 nmol/L, 7-144 
nmol/L, versus non-HT 27 nmol/L, 12-70 nmol/L). 
In patients with HT, one episode with a neopterin 
value below 45 nmol/L was recorded compared to 
eight out of 16 in the non-HT group (1 /6 versus 8 /  16; 
not significant). 
There was a difference in neopteridcytokine 
correlations (r-values) in fever episodes with bacteremia 
(Gram-negative and Gram-positive pooled together) 
as compared to the BCN episodes. At time 0, all 
cytokines (except IL-6) tended to be negatively cor- 
related (high neopterin/low cytokine and vice versa) 
with neopterin in BCN episodes, and positively 
correlated (low neopterin/low cytokine and high 
neopteridhigh cytokine) in the bacteremic episodes 
(except INF-)I; Table 1). This was most clearly seen 
in the TNF-a/neopterin correlations, which were 
statistically significant in both the bacteremic and the 
BCN groups at time 0 (Table 1). In the BCN group, 
one out of eight patients had a clear site of infection 
(pneumonia). This patient had a high TNF-a value 
(48 pg/niL) and a low neopterin value (13 nmol/L). 
Of the remaining seven patients, with no clear site of 
infection, five had a high neopterin value in combina- 
tion with a low TNF-a value (Figure 3). 
At peak value (obtained 2-24 h after start of fever), 
all cytokines were positively correlated in bacteremic 
patients in contrast to patients with BCN episodes, in 
which less positive or negative correlations were recorded 
(with the exception of IFN-)I; Table 1). 
DISCUSSION 
This study demonstrates that neutropenic patients, after 
chemotherapy, are able to respond with increased levels 
of serum neopterin during fever. This finding is in 
opposition to the results of Osterman et al, who did not 
detect any rise in neopterin levels 1 day after start of 
fever in patients with neutropenia and fever, including 
patients with both severe sepsis and septic shock 181. 
This difference may be explained by the time at which 
samples were obtained in the two studies. The peak 
neopterin values in our patients were reached 2-4 h 
after start of fever, and neopterin levels were back to 
baseline levels at  12-24 h. 
Neopterin is mainly secreted by monocytes and 
macrophages, but secretion of small amounts from 
fibroblasts and B-lymphocytes has been demonstrated 
in vitro [17]. All patients in this study were profoundly 
pancytopenic, including nionocytopenia, and thus 
macrophages in the niononuclear phagocytic system 
may be the prime source of neopterin in these patients. 
We could not, a5 intended, demonstrate any 
discriminative ability of serum neopterin values to 
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Figure 3 Serum neopteriii and seruiii TNF-a correlations 
at  ttart of fever in BCN episodes (filled circles; n=8; 
r =  -0.73) and bactereinias (unfilled circles; ir=12. r=0.74). 
Table 1 Correlations (r-values) between rieopterin and cytokine values at  time 0 and at peak values 2-24 h after start of 
fever in relation to blood culture findings 
- 
Time 0 2-24 11 
I?CN Hacteremia BCN Bxteremi,i 
Y-VdIUC 0 1 )  v-value ( t i )  r-value ( t i )  r-value ( i l )  
TNF-u - 0.88 *(8) 0.67'(12) -0.31 (6) 0.86' (7) 
IL-l ra -iJ.41 (8) 0.14 (1 1) -(1.39 (7) li.57 (7) 
IFN-y -0.67 (7) -0.03 (12) 0.78 (7) U.78 (7) 
IL-6 0.i)S (8) 0.46 (12) 0.25 (7) 0.83 (6) 
IL-10 -0.30 (5) 0.33 (10) 0.25 (7) 0.64 ( 7 )  
~~~ -~ 
'p<O.O4 (Spearman rank correlation test). 
Number  of patients (only the first fever episode per patient is included 111 thiq analysis) arc given within parenthew\ 
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predict Gram-positive bacteremia. Cellular immune 
activation measured as serum neopterin values was not 
different with regard to blood culture findings. Both 
high and low values were seen in both Gram-positive 
bacteremias and BCN fever episodes. However, in 
patients with Gram-negative bacteremia, values exceed- 
ing 40 nmol/L were recorded in six of seven episodes. 
High neopterin values have been documented in 
non-neutropenic patients with septic shock [14,15,18]. 
In this study, no statistically significant difference 
was detected between patients with or without HT, 
although a trend towards higher values was seen in the 
hypotensive group. This lack of statistically significant 
difference may be explained by the small number of 
patients in this study and the fact that only one of the 
hypotensive patients developed severe septic shock, 
while the others responded to intravenous fluid therapy. 
Neopterin is released mainly after IFN-y stimula- 
tion [17]. In non-febrile patients with hematologic 
malignancies and anemia, a correlation was found 
between IFN-yand neopterin values [19]. In our study 
of febrile patients no such correlation was found at start 
of fever, although at peak neopterin value IFN-y was 
the only cytokine with a trend towards a positive 
correlation with neopterin (p=0.054) also in the BCN 
group. 
The inverse correlation between cytokines seen in 
the BCN group, most clearly in the TNF-alneopterin 
correlations, is interesting. Five of the seven patients 
without any clear origin of fever had high neopterin 
values combined with low TNF-a values. One possible 
explanation could be infection/reactivation of viral 
agents. 
The mechanism in FUO in neutropenic patients is 
still an enigma. Patients with FUO generally have a 
good prognosis and they uniformly show the highest 
response rates to empirical antibiotic therapy [3]. One 
possible mechanism could be translocation of endo- 
toxins through a damaged gut. This notion is supported 
by a study by Jackson et al, in which patients under- 
going bone marrow transplantation (both allogenic 
and autologous) had gut mucosal damage, assessed by 
lactose/mannitol ratios, that was associated with endo- 
toxemia [20]. Furthermore, endotoxemia was seen in 
70% of all patients with FUO [20]. Other studies, 
however, that included non-transplantation neutropenic 
patients, have not shown any correlation between 
endotoxemia and fever [10,21-231. There are probably 
several mechanisms involved in patients with neutro- 
penia and FUO, and this area needs further study. 
In conclusion, the results of this study demonstrate 
that neutropenic patients have increased neopterin 
levels in the first hours after start of fever, indicating a 
cellular immune response. High levels of neopterin 
concomitant with low cytokine values were seen 
in several non-bacteremic fever episodes. The clinical 
relevance of this finding is unclear and it needs to be 
confirmed in larger series of patients. 
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